Abstract:Cytotoxic T lymphocytes and NK cells play an important role in eliminating malignant tumor cells and the number and activity of tumor-infiltrating T cells represent a good marker for tumor prognosis. Based on these findings, immunotherapy, e.g., checkpoint blockade, has received considerable attention during the last couple of years. However, for the majority of patients, immune control of their tumors is gray theory as malignant cells use effective mechanisms to outsmart the immune system. Increasing evidence suggests that changes in tumor metabolism not only ensure an effective energy supply and generation of building blocks for tumor growth but also contribute to inhibition of the antitumor response. Immunosuppression in the tumor microenvironment is often based on the mutual metabolic requirements of immune cells and tumor cells. Cytotoxic T and NK cell activation leads to an increased demand for glucose and amino acids, a well-known feature shown by tumor cells. These close metabolic interdependencies result in metabolic competition, limiting the proliferation, and effector functions of tumor-specific immune cells. Moreover, not only nutrient restriction but also tumor-driven shifts in metabolite abundance and accumulation of metabolic waste products (e.g., lactate) lead to local immunosuppression, thereby facilitating tumor progression and metastasis. In this review, we describe the metabolic interplay between immune cells and tumor cells and discuss tumor cell metabolism as a target structure for cancer therapy. Metabolic (re)education of tumor cells is not only an approach to kill tumor cells directly but could overcome metabolic immunosuppression in the tumor microenvironment and thereby facilitate immunotherapy.

Immunometabolic reprogramming, another cancer hallmark

Metabolic rewiring and communication in cancer immunity

The Emerging Hallmarks of Cancer Metabolism

Tumor cell metabolic reprogramming and hypoxic immunosuppression: driving carcinogenesis to metastatic colonization

Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy

Metabolic Modifications, Inflammation, and Cancer Immunotherapy

Metabolic regulation in the immune response to cancer

Immunometabolism in cancer: basic mechanisms and new targeting strategy

The Epigenetic Hallmarks of Cancer

Cancer immunometabolism: advent, challenges, and perspective

Metabolic reprogramming and epigenetic modifications on the path to cancer

The Critical Function of Metabolic Reprogramming in Cancer Metastasis

Hallmarks of Cancer: The Next Generation

Immunological Aspects of Cancer Cell Metabolism

Cancer metabolism and carcinogenesis

Metabolic Hallmarks of Tumor and Immune Cells in the Tumor Microenvironment

Metabolic Reprogramming in Cancer: Implications for Immunosuppressive Microenvironment

Cancer cell metabolic reprogramming: a keystone for the response to immunotherapy

The hallmarks of cancer metabolism: Still emerging

Immunometabolism in cancer: A journey into innate and adaptive cells

Metabolic Interplay in the Tumor Microenvironment: Implications for Immune Function and Anticancer Response